MCIM
XBI icon

Meadow Creek Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Meadow Creek Investment Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16
Closed -$1K – 1371
2019
Q1 		$1K Buy
+16
New +$1.36K ﹤0.01% 1341

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Meadow Creek Investment Management's XBI Position: Q2 2019 in Review

Meadow Creek Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2019, closing a stake of 16 shares — an estimated $1K sold.

Meadow Creek Investment Management first reported a position in XBI in Q1 2019 and held it in 1 quarter. The position peaked at $1K in Q1 2019. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.

  • Meadow Creek Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2019 after selling out during the quarter.
  • Meadow Creek Investment Management sold 16 State Street SPDR S&P Biotech ETF shares in Q2 2019, an estimated $1K.
  • Meadow Creek Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 1 quarter.
  • Meadow Creek Investment Management's State Street SPDR S&P Biotech ETF position peaked at $1K in Q1 2019.
  • 424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.

Based on Meadow Creek Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.